These countries have been more successful with managing the virus than the United States and the European Union.
COVID-19 is driving patients to seek telehealth solutions, and it won’t be a short-term boom.
The Abbott ID NOW test may return false negative results.
Diagnostic companies are hustling to increase availability of testing.
The agency will continue to work with companies developing diagnostics relevant to the coronavirus outbreak in an effort to rapidly bring technologies to market.
Due to the public health emergency, the agency is implementing the guidance document immediately, without public comment.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
FDA, CDC and other agencies are trying to foster the development of diagnostics, therapeutics and vaccines that help address the outbreak.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.